Modulating Exercise Dosage to Improve Concussion Recovery
Key facts
- Who runs it
- University of Colorado, Denver
- Where
- Aurora, Boston, and Cambridge, United StatesSee the 3 sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 1/2
- People taking part
- 178 people, planned
- Started
- 5 Aug 2022
- Expected to end
- 1 Feb 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- High Dose Exercise
- Record updated
- 31 August 2026
Who can take part
- Age
- 13 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- 13-18 years of age
- Post-Concussion Symptom Scale (PCSS) score >10 to ensure participants are not recovered by enrollment
- Concussion diagnosis by a sports medicine physician
Who cannot take part
- Concussion <6 months before enrollment (excluding the current injury)
- Pre-existing neurological disorders
- Exercise contraindications
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 13 and 18 years old?
Where in United States
- University of Colorado DenverAurora, United StatesContact: David R Howell, PhDTaking people
- Boston Children's HospitalBoston, United StatesContact: Danielle Hunt, MSTaking people
- Spaulding Rehabilitation HospitalCambridge, United StatesContact: Andrew Taylor, PhDTaking people
About the trial
What the trial wants to find out
Aerobic exercise has emerged as an effective treatment to reduce sport-related concussion symptom severity, yet existing work lacks rigor regarding the precise exercise volume and intensity required to elicit therapeutic effects, how exercise can alter concussion-related pathophysiology, and whether exercise can prevent the development of secondary sequelae. Our objective is to examine if a high dose exercise program (higher volume than currently prescribed at an individualized, safe intensity level) initiated within 21 days of concussion results in faster symptom resolution, altered physiological function, or reduced secondary sequalae. Findings from this research will lead to more rigorous and precise rehabilitation guidelines and improved understanding about how exercise affects neurophysiological function among adolescents with concussion.
The 2 groups in the trial
- High Dose ExerciseTreatment being tested
The investigators will provide exercise dose recommendations for initial visit until symptom resolution, and revise upon symptom resolution (to use for the subsequent 8 weeks). These include intensity (target HR) and volume (frequency/duration). Intensity is calculated as 90% of the HR at the end of the exercise test. The volume recommendation is 150 mins/week (\~30 min/day; 5 days/week). The mode of exercise is another consideration. This will be left to participant preference, so that the investigators do not exclude potential participants due to lack of access to specific exercise equipment.
- Standard-of-careNo study treatment, for comparison
Participants are instructed to perform activity in line with physician recommendations. This consists of a general recommendation (no specific HR/volume) or symptom limited physical activity.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Modulating Exercise Dosage to Improve Concussion Recovery: A Randomized Clinical Trial
- Criteria questions
- Built from NCT05434130, who can take part
- Record updated
- 31 August 2026